Mikroscan Technologies

Executive Summary

Mikroscan Technologies is a US-based medical device company specializing in affordable and portable digital pathology and telemicroscopy solutions. Founded in 2004 and headquartered in Sacramento, the company designs compact systems that enable remote pathology consultations and digital slide sharing, aiming to connect patients with expert pathologists irrespective of geography. Mikroscan addresses a critical need in diagnostics by improving access to timely and accurate pathology services, particularly in underserved areas. The company's products are designed to be cost-effective and user-friendly, facilitating adoption in small labs, clinics, and field hospitals. Despite limited public information on recent funding or revenue, Mikroscan's niche focus on portable digital pathology positions it well in a growing market driven by telemedicine trends and the need for decentralized diagnostics. However, the company faces competition from larger players and must navigate regulatory hurdles. Overall, Mikroscan's potential hinges on its ability to scale distribution, secure regulatory clearances, and form strategic partnerships.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for next-generation portable scanner60% success
• Q4 2026Partnership with a major telemedicine or hospital network45% success
• TBDNew funding round or grant announcement50% success